Form 4 for HCAT Health Catalyst, Inc.
Accepted 2023-03-24 00:00:00 ET · period of report 2023-03-22 · accession 0001562180-23-003116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-24 | 2023-03-22 | HCAT | Horstmeier Paul | COO | M - OptEx | $4.42 | +50.0K | 204.9K | +32% | +$221.0K |
| D | 2023-03-24 | 2023-03-22 | HCAT | Horstmeier Paul | COO | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | M | A | 50,000 | $4.42 | 204,880 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | M | D | 50,000 | $0.00 | 0 | D | $4.42 · — to 2023-07-01 | 50,000 Common Stock | (F1) 25% of the 50,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested in equal monthly installments until the option vested in full on July 1, 2017. |